Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review
Authors
Keywords
Epilepsy, Anti-seizure medications, Irritability, Anger, Aggression, Behavioral adverse events
Journal
EPILEPSY & BEHAVIOR
Volume 118, Issue -, Pages 107939
Publisher
Elsevier BV
Online
2021-04-09
DOI
10.1016/j.yebeh.2021.107939
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis
- (2020) Christian Brandt et al. EPILEPSY & BEHAVIOR
- Cognitive, behavioural and sleep-related adverse effects on introduction of levetiracetam versus oxcarbazepine for epilepsy
- (2019) A. Thelengana et al. EPILEPSY RESEARCH
- Brivaracetam in adults with drug-resistant epilepsy and psychiatric comorbidities
- (2019) Evangelia Theochari et al. EPILEPSY & BEHAVIOR
- The impact of perampanel treatment on quality of life and psychiatric symptoms in patients with drug-resistant focal epilepsy: An observational study in Italy
- (2019) Francesco Deleo et al. EPILEPSY & BEHAVIOR
- Effect of brivaracetam on the anger levels of epilepsy patients. A prospective open-labelled controlled study
- (2019) Manuel Toledo et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Efficacy and impact on cognitive functions and quality of life of perampanel as first add-on therapy in patients with epilepsy: A retrospective study
- (2019) Raffaele Rea et al. EPILEPSY & BEHAVIOR
- An Italian multicentre study of perampanel in progressive myoclonus epilepsies
- (2019) Laura Canafoglia et al. EPILEPSY RESEARCH
- Retrospective study of perampanel efficacy and tolerability in myoclonic seizures
- (2018) F. J. Gil-López et al. ACTA NEUROLOGICA SCANDINAVICA
- Pyridoxine Add-On Treatment for the Control of Behavioral Adverse Effects Induced by Levetiracetam in Children: A Case-Control Prospective Study
- (2018) Silvia Marino et al. ANNALS OF PHARMACOTHERAPY
- Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures
- (2018) Eva Andermann et al. EPILEPSY & BEHAVIOR
- A retrospective, multicentre study of perampanel given as monotherapy in routine clinical care in people with epilepsy
- (2018) Antonio Gil-Nagel et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Tolerability, efficacy and retention rate of Brivaracetam in patients previously treated with Levetiracetam: A monocenter retrospective outcome analysis
- (2018) Martin Hirsch et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice
- (2018) Vicente Villanueva et al. ACTA NEUROLOGICA SCANDINAVICA
- Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel
- (2018) Cerine C. Hansen et al. BEHAVIOURAL NEUROLOGY
- Perampanel in 12 patients with Unverricht-Lundborg disease
- (2017) Arielle Crespel et al. EPILEPSIA
- Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany
- (2017) Isabel Steinig et al. EPILEPSIA
- Psychiatric side effects and antiepileptic drugs: Observations from prospective audits
- (2017) Linda J. Stephen et al. EPILEPSY & BEHAVIOR
- A two-year retrospective evaluation of perampanel in patients with highly drug-resistant epilepsy and cognitive impairment
- (2017) Bernd Huber et al. EPILEPSY & BEHAVIOR
- Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy
- (2017) Baibing Chen et al. EPILEPSY & BEHAVIOR
- Randomized controlled antiepileptic drug trials miss almost all patients with ongoing seizures
- (2017) Bernhard J. Steinhoff et al. EPILEPSY & BEHAVIOR
- Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy—A monocenter survey
- (2017) Bernhard J. Steinhoff et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Preliminary Asian experience of using perampanel in clinical practice
- (2017) Hsing-I Chiang et al. Biomedical Journal
- Efficacy and tolerability of anti-epileptic drugs-an internet study
- (2016) U. C. Wieshmann et al. ACTA NEUROLOGICA SCANDINAVICA
- Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein
- (2016) Martyn D. Wood et al. EPILEPSIA
- Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment
- (2016) Henrik Klitgaard et al. EPILEPSIA
- Adjunctive perampanel in refractory epilepsy: Experience at tertiary epilepsy care center in Tours
- (2016) Aude Maurousset et al. EPILEPSY & BEHAVIOR
- Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study
- (2016) V. Villanueva et al. EPILEPSY RESEARCH
- Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel
- (2015) Alan B. Ettinger et al. EPILEPSIA
- An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam
- (2015) Stephen L. Yates et al. EPILEPSY & BEHAVIOR
- Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy
- (2015) Jacqueline A. French et al. NEUROLOGY
- First clinical experiences with perampanel-The Kork experience in 74 patients
- (2014) Bernhard J. Steinhoff et al. EPILEPSIA
- Clinical experience with perampanel: Focus on psychiatric adverse effects
- (2014) Helen Coyle et al. EPILEPSY & BEHAVIOR
- A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria
- (2014) Bernhard J. Steinhoff et al. EPILEPSY RESEARCH
- Behavioral Adverse Effects of Antiepileptic Drugs in Epilepsy
- (2012) Clare Margaret Eddy et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Self-reported symptoms in patients on antiepileptic drugs in monotherapy
- (2011) U. C. Wieshmann et al. ACTA NEUROLOGICA SCANDINAVICA
- Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments
- (2011) Chiara Luoni et al. EPILEPSIA
- Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties
- (2011) Michel Gillard et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Levetiracetam monotherapy—Outcomes from an epilepsy clinic
- (2011) Linda J. Stephen et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Assessing the unmet treatment need in partial-onset epilepsy: Looking beyond seizure control
- (2010) Bettina Schmitz et al. EPILEPSIA
- Efficacy and safety of levetiracetam as adjunctive therapy in adult patients with uncontrolled partial epilepsy: The Asia SKATE II Study
- (2010) Patrick Kwan et al. EPILEPSY & BEHAVIOR
- Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up
- (2009) R. Kuba et al. ACTA NEUROLOGICA SCANDINAVICA
- Adverse antiepileptic drug effects: Toward a clinically and neurobiologically relevant taxonomy
- (2009) P. Perucca et al. NEUROLOGY
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2009) Alessandro Liberati et al. PLOS MEDICINE
- Pyridoxine supplementation for the treatment of levetiracetam-induced behavior side effects in children: Preliminary results
- (2008) Philippe Major et al. EPILEPSY & BEHAVIOR
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More